You are here
- Home
- Therapy Areas
- Cardiovascular
A Phase I, Single Centre, Single-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD2820 after Administration of Multiple Ascending Doses
- Disease
- obesity
- Drug Name
- AstraZeneca Cardiovascular development drugs
- Sponsor
- AstraZeneca
- Drug Status
- Discontinued
- Phase
- I
- Start Date
- Mar 14, 2012
- Study Name
- D3870C00002
- Study Id
- D3870C00002
- ClinicalTrials.gov ID
- NCT01469923
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
